Acute Promyelocytic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Promyelocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2025-05-06EMA Withdrawn: Arsenic trioxide Mylan (arsenic trioxide) — Mylan Ireland Limited
The EMA has withdrawn the arsenic trioxide product Arsenic trioxide Mylan (Mylan Ireland Limited) used for acute promyelocytic leukemia.
-
CLINICAL_TRIALS withdrawal · 2018-07-02Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial of gemtuzumab ozogamicin for adults with acute myeloid leukemia, including acute promyelocytic leukemia and various cytogeneti…
-
CLINICAL_TRIALS withdrawal · 2015-10-27Clinical Trial Update: New Retinoid Agent Combined With Arsenic Trioxide for Untreated Acute Promyelocytic Leukemia [Phase 2]
A Phase 2 trial evaluating a new retinoid agent in combination with arsenic trioxide for untreated acute promyelocytic leukemia has been wit…
-
CLINICAL_TRIALS withdrawal · 2013-03-22Clinical Trial Update: Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Homoharringtonine for patients with refractory acute promyelocytic leukemia has been withdrawn.